| Clinical global response: 1b. Average clinical global status score (various scales, high=worse) ‐ short term (2 ‐ 12 weeks) ‐ skewed results | |||||||
|---|---|---|---|---|---|---|---|
| Study | NRI | NRI mean | NRI SD | NRI N | Placebo mean | Placebo SD | Placebo N |
| CGI‐I | |||||||
| Schutz 2001 | Reboxetine | 3.4 | 1.35 | 12 | 3.07 | 1.22 | 11 |
| CGI‐S | |||||||
| Hinkelmann 2013 | Reboxetine | 4.2 | 1.5 | 19 | 3.6 | 1.3 | 16 |
| Poyurovsky 2003 | Reboxetine | 3.1 | 1.3 | 10 | 3 | 1.1 | 10 |
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.